Issue Information

ISTH Academy, Faculty / Presenters, 4151195

The intricate allostery in factor VIIa: triggering the trigger

ISTH Academy, Ole H. Olsen, 4151196

Hematological causes of acute ischemic stroke in younger individuals

ISTH Academy, Faculty / Presenters, 4151197

Déjà vu all over again: a recurrent flaw in anticoagulant study design

ISTH Academy, Faculty / Presenters, 4151198

Moving medical management to community care: time to consider thromboprophylaxis for “ambulatory” patients?

ISTH Academy, Alexander Cohen, 4151199

Thrombocytopenia in pediatrics: bridging the gap from discovery to management—a long way to go

ISTH Academy, , 4151200

Commentary on “Antiproliferative agent attenuates post-thrombotic vein wall remodeling in murine and human subjects”

ISTH Academy, Peter Henke, 4151201

Circulating tumor DNA: the dawn of new, clinically scalable biomarkers for thromboembolism

ISTH Academy, , 4151203

New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A receptor

ISTH Academy, Faculty / Presenters, 4151204

Management of antithrombotic therapy in patients undergoing dental procedures

ISTH Academy, Behnood Bikdeli, 4151205

Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B

ISTH Academy, Faculty / Presenters, 4151206

Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation

ISTH Academy, Johannes Oldenburg, 4151207

Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice

ISTH Academy, Lawrence Goldfinger, 4151209

Alterations in visible light exposure modulate platelet function and regulate thrombus formation

ISTH Academy, Faculty / Presenters, 4151210

Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism

ISTH Academy, Sameer Parikh, 4151212

Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension

ISTH Academy, , 4151213

Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank

ISTH Academy, Pavan Bendapudi, 4151214

Incidence and risk factors for postthrombotic syndrome in neonates and children in a single-center cohort study

ISTH Academy, Faculty / Presenters, 4151215

Management and outcomes in patients with tumor thrombus: a retrospective cohort study

ISTH Academy, Tzu-Fei Wang, 4151217

Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice

ISTH Academy, , 4151219

Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV

ISTH Academy, Moniek de Maat, 4151220

Critical role for platelet Ral GTPases in regulating venous thrombosis in mice

ISTH Academy, Alastair Poole, 4151222

Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes

ISTH Academy, , 4151224

A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation

ISTH Academy, Yi Wu, 4151225

Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent

ISTH Academy, , 4151226

High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia

ISTH Academy, Faculty / Presenters, 4151229

Antiproliferative agent attenuates postthrombotic vein wall remodeling in murine and human subjects

ISTH Academy, , 4151230

2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibod

ISTH Academy, Faculty / Presenters, 4151231

Recommendations for defining disturbed flow as laminar, transitional, or turbulent in assays of hemostasis and thrombosis: communication from the ISTH SSC Subcommittee on Biorheology

ISTH Academy, Faculty / Presenters, 4151232

Annoucements

ISTH Academy, Faculty / Presenters, 4151233

Issue Information

ISTH Academy, Faculty / Presenters, 4151512

The intricate allostery in factor VIIa: triggering the trigger

ISTH Academy, Ole H. Olsen, 4151513

Hematological causes of acute ischemic stroke in younger individuals

ISTH Academy, Faculty / Presenters, 4151514

Moving medical management to community care: time to consider thromboprophylaxis for “ambulatory” patients?

ISTH Academy, Alexander Cohen, 4151516

Thrombocytopenia in pediatrics: bridging the gap from discovery to management—a long way to go

ISTH Academy, , 4151517

Commentary on “Antiproliferative agent attenuates post-thrombotic vein wall remodeling in murine and human subjects”

ISTH Academy, Peter Henke, 4151518

Circulating tumor DNA: the dawn of new, clinically scalable biomarkers for thromboembolism

ISTH Academy, , 4151520

Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation

ISTH Academy, Johannes Oldenburg, 4151524

Same-day emergency care: a retrospective observational study of the incidence and predictors of venous thromboembolism following hospital-based acute ambulatory medical care

ISTH Academy, Faculty / Presenters, 4151525

Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice

ISTH Academy, Lawrence Goldfinger, 4151526

Alterations in visible light exposure modulate platelet function and regulate thrombus formation

ISTH Academy, Faculty / Presenters, 4151527

Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism

ISTH Academy, Sameer Parikh, 4151529

Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension

ISTH Academy, , 4151530

Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank

ISTH Academy, Pavan Bendapudi, 4151531

Incidence and risk factors for postthrombotic syndrome in neonates and children in a single-center cohort study

ISTH Academy, Faculty / Presenters, 4151532

Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study

ISTH Academy, Faculty / Presenters, 4151533

Management and outcomes in patients with tumor thrombus: a retrospective cohort study

ISTH Academy, Tzu-Fei Wang, 4151534

Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics

ISTH Academy, Renee Ruhaak, 4151535

Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV

ISTH Academy, Moniek de Maat, 4151537

Impact of limited language proficiency on participation in venous thromboembolism research: a retrospective analysis

ISTH Academy, Yan Xu, 4151538

Critical role for platelet Ral GTPases in regulating venous thrombosis in mice

ISTH Academy, Alastair Poole, 4151539

Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes

ISTH Academy, , 4151541

A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation

ISTH Academy, Yi Wu, 4151542

Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent

ISTH Academy, , 4151543

Genetic engineering of megakaryocytes from blood progenitor cells using messenger RNA lipid nanoparticles

ISTH Academy, Christian Kastrup, 4151544

A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome

ISTH Academy, Marie-Christine Alessi, 4151545

High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia

ISTH Academy, Faculty / Presenters, 4151546

2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibod

ISTH Academy, Faculty / Presenters, 4151548

Recommendations for defining disturbed flow as laminar, transitional, or turbulent in assays of hemostasis and thrombosis: communication from the ISTH SSC Subcommittee on Biorheology

ISTH Academy, Faculty / Presenters, 4151549

Annoucements

ISTH Academy, Faculty / Presenters, 4151550

The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women

ISTH Academy, Grace Tang, 4158543

Mini-clusters of postadenovirus VITT

ISTH Academy, Theodore (Ted) Warkentin, 4158544

Venous thromboembolism still leads on maternal death

ISTH Academy, Sue Pavord, 4158545

Thromboprophylaxis in multiple myeloma

ISTH Academy, Laurent Frenzel, 4158546

Transfusion in trauma: empiric or guided therapy?

ISTH Academy, Nicola Curry, 4158547

Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies

ISTH Academy, Ingrid Pabinger, 4158548

Structural bioinformatics for rational drug design

ISTH Academy, Kanin Wichapong, 4158549

Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps

ISTH Academy, , 4158551

Should a history of venous thromboembolism be considered a contraindication for scuba diving?

ISTH Academy, Nicolas Gendron, 4158559

Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients

ISTH Academy, Kochawan Boonyawat, 4158560

Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6789 total hip and total knee arthroplasty patients

ISTH Academy, Faculty / Presenters, 4158561

Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial

ISTH Academy, Runhui Wu, 4158562

Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism

ISTH Academy, , 4158563

Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study

ISTH Academy, , 4158564

Occurrence and management of thrombosis recurrence and bleeding in low-molecular-weight heparin-treated patients with cancer-associated thrombosis: a French nationwide cohort study

ISTH Academy, , 4158565

Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value

ISTH Academy, Faculty / Presenters, 4158568

Health literacy in pediatric thrombosis: a landscape analysis

ISTH Academy, Laura Avila, 4158569

Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis

ISTH Academy, Faculty / Presenters, 4158570

Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study

ISTH Academy, Faculty / Presenters, 4158571

A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine

ISTH Academy, Faculty / Presenters, 4158574

Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis

ISTH Academy, , 4158575

Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans

ISTH Academy, Jamie Lo, 4158578

Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency

ISTH Academy, A. Koneti Rao, 4158581

Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT

ISTH Academy, Faculty / Presenters, 4158582

Carbon dioxide alleviates platelet storage lesions via stimulating fatty acid metabolism and reducing platelet glucose consumption

ISTH Academy, Wen Yin, 4158583

Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients

ISTH Academy, Catherine Hayward, 4158584

Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice

ISTH Academy, Bart van Vlijmen, 4158586

Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls

ISTH Academy, Thijs van Mens, 4158587

Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic

ISTH Academy, , 4158588

Altered clot structure in pregnant women who will develop postpartum hemorrhage

ISTH Academy, Faculty / Presenters, 4158596

Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series

ISTH Academy, Faculty / Presenters, 4158597

Acquired factor V inhibitor in a case of pediatric venous thrombosis

ISTH Academy, Faculty / Presenters, 4158598

Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura

ISTH Academy, , 4158600

Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism

ISTH Academy, , 4176032

Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study

ISTH Academy, , 4176033

Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm

ISTH Academy, Mohammad Qadura, 4176035

A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine

ISTH Academy, Faculty / Presenters, 4176043

Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease

ISTH Academy, Faculty / Presenters, 4176045

Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations

ISTH Academy, , 4176046

Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans

ISTH Academy, Jamie Lo, 4176047